» Articles » PMID: 17261098

Women with Gestational Diabetes Mellitus in the ACHOIS Trial: Risk Factors for Shoulder Dystocia

Overview
Date 2007 Jan 31
PMID 17261098
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gestational diabetes mellitus (GDM) is associated with increased risk of fetal macrosomia and shoulder dystocia. However, not all women with GDM and fetal macrosomia have shoulder dystocia.

Aims: To identify the risk factors for shoulder dystocia in women with gestational diabetes using data from women recruited into the routine care group of the ACHOIS trial.

Methods: A secondary analysis was performed on data collected from women enrolled in the ACHOIS trial. Bivariate analyses were performed using the Fisher exact test. Variables found to be significantly associated with shoulder dystocia and previously identified risk factors were used as explanatory variables in multivariate analyses.

Results: A positive relationship was found between the severity of maternal fasting hyperglycaemia and the risk of shoulder dystocia, with a 1 mmol increase in fasting oral glucose-tolerance test leading to a relative risk (RR) of 2.09 (95% CI 1.03-4.25). Shoulder dystocia occurred more often in births requiring operative vaginal delivery (RR 9.58, 95% CI 3.70-24.81, P < 0.001). Macrosomic and large-for-gestational-age infants were more likely to have births complicated by shoulder dystocia (RR 6.27, 95% CI 2.33-16.88, P < 0.001 and RR 4.57, 95% CI 1.74-12.01, P < 0.005, respectively). Fetal macrosomia was the only variable to maintain its significance in all multivariate analyses.

Conclusions: Fetal macrosomia is the strongest independent risk factor for shoulder dystocia. Effective preventative strategies are needed.

Citing Articles

Microscopic changes and gross morphology of placenta in women affected by gestational diabetes mellitus in dietary treatment: A systematic review.

Molitierno R, Imparato A, Iavazzo N, Salzillo C, Marzullo A, Lagana A Open Med (Wars). 2025; 20(1):20251142.

PMID: 39958976 PMC: 11826244. DOI: 10.1515/med-2025-1142.


Associations between maternal metabolic conditions and neurodevelopmental conditions in offspring: the mediating effects of obstetric and neonatal complications.

Chen S, Wang X, Lee B, Gardner R BMC Med. 2023; 21(1):422.

PMID: 37936224 PMC: 10631144. DOI: 10.1186/s12916-023-03116-x.


Glucose Levels of the Oral Glucose Tolerance Test (oGTT) Can Predict Adverse Pregnancy Outcomes in Women with Gestational Diabetes (GDM).

Balke S, Weid P, Fangmann L, Rostin P, Henrich W, Koenigbauer J J Clin Med. 2023; 12(11).

PMID: 37297904 PMC: 10254013. DOI: 10.3390/jcm12113709.


Maternal obesity: Perinatal implications.

Reed J, Case S, Rijhsinghani A SAGE Open Med. 2023; 11:20503121231176128.

PMID: 37275842 PMC: 10233600. DOI: 10.1177/20503121231176128.


A multi-centered trial investigating gestational treatment with ursodeoxycholic acid compared to metformin to reduce effects of diabetes mellitus (GUARD): a randomized controlled trial protocol.

Lovell H, Mitchell A, Ovadia C, Pitrelli N, Briley A, Singh C Trials. 2022; 23(1):571.

PMID: 35854327 PMC: 9295112. DOI: 10.1186/s13063-022-06462-y.